Cargando…
Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876657/ https://www.ncbi.nlm.nih.gov/pubmed/36712681 http://dx.doi.org/10.3389/fphar.2022.1123542 |
| _version_ | 1784878210890072064 |
|---|---|
| author | Bhagwat, Geeta S. Athawale, Rajani B. Gude, Rajeev P. Md, Shadab Alhakamy, Nabil A. Fahmy, Usama A. Kesharwani, Prashant |
| author_facet | Bhagwat, Geeta S. Athawale, Rajani B. Gude, Rajeev P. Md, Shadab Alhakamy, Nabil A. Fahmy, Usama A. Kesharwani, Prashant |
| author_sort | Bhagwat, Geeta S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9876657 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98766572023-01-26 Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy Bhagwat, Geeta S. Athawale, Rajani B. Gude, Rajeev P. Md, Shadab Alhakamy, Nabil A. Fahmy, Usama A. Kesharwani, Prashant Front Pharmacol Pharmacology Frontiers Media S.A. 2023-01-11 /pmc/articles/PMC9876657/ /pubmed/36712681 http://dx.doi.org/10.3389/fphar.2022.1123542 Text en Copyright © 2023 Bhagwat, Athawale, Gude, Md, Alhakamy, Fahmy and Kesharwani. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Bhagwat, Geeta S. Athawale, Rajani B. Gude, Rajeev P. Md, Shadab Alhakamy, Nabil A. Fahmy, Usama A. Kesharwani, Prashant Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| title | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| title_full | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| title_fullStr | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| title_full_unstemmed | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| title_short | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| title_sort | corrigendum: formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876657/ https://www.ncbi.nlm.nih.gov/pubmed/36712681 http://dx.doi.org/10.3389/fphar.2022.1123542 |
| work_keys_str_mv | AT bhagwatgeetas corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT athawalerajanib corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT guderajeevp corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT mdshadab corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT alhakamynabila corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT fahmyusamaa corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT kesharwaniprashant corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy |